HIPRABOVIS IBR MARKER LIVE vaccine against infectious bovine rhinotracheitis: increased incidence of anaphylactic-type reactions in cattle

Since the beginning of 2022, there has been an increase in the incidence of anaphylactic-type reactions in cattle after administration of HIPRABOVIS IBR MARKER LIVE vaccine. The cause has not yet been clearly identified and investigations are ongoing. Veterinarians are asked to report any adverse reactions as soon as possible and, if possible, to provide a complete history of vaccinations and an overview of other veterinary medicinal products previously used.

Adtralza (tralokinumab)

Active substance   tralokinumab
Holder LEO Pharma
Status Running
Indication severe atopic dermatitis in adolescent patients (12- <18 years) who are cand

Pritelivir

<
Active substance   Pritelivir
Holder myTomorrows
Status Rnning
Indication treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient
Public documents Approbation
Active substance daunorubicin and cytarabine
Holder Bionical Limited T/A Bionical Emas
Status Running
Indication Newly diagnosed, treatment-related acute myeloid Leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
Public documents Ap

Call for Belgian laboratories to apply to become the European Union reference laboratory for in vitro diagnostic medical devices

The European Commission has launched a call for laboratories of Member States to apply to become European Union reference laboratories (EURLs) for in vitro diagnostic (IVD) medical devices. The possible designation of such EURLs is provided for in article 100 of the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

West Nile virus: launch of weekly overview of affected areas for temporary exclusion of candidate donors in blood establishments or human body material establishments

In order to prevent the spread of West Nile virus through contaminated blood or human body material, candidate donors from areas where autochthonous cases are found must wait before donating. From now until the end of November, the FAMHP will provide weekly updates on the affected areas. This weekly update is based on data from the European Centre for Disease Prevention and Control (ECDC).

What should you do with expired or unused medicines? Do not throw them away but take them to the pharmacy!

Expired or unused medicines do not belong in your home pharmacy as they can be dangerous for your own health. Disposing of medicines in the rubbish bin, the sink or the toilet can also be dangerous for the environment. Therefore, bring your expired or unused medicines to the pharmacy. The pharmacist will take care of the destruction of the medicines.

Expired or unused medicines

What should you do with expired or unused medicines?
Expired or unused medicines do not belong in your home pharmacy. Using expired medicines can be dangerous for your own health: the properties of the medicine change over time, making it impossible to guarantee its effectiveness and safety. Disposing of medicines in the rubbish bin, the sink or the toilet can be dangerous for the environment.

PRAC July 2022 – New measures for medicinal products containing nomegestrol or chlormadinone and start of assessment of neurodevelopmental disorders when using topiramate

During its July 2022 meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA)  recommends new measures to minimise the risk of meningioma with medicines containing nomegestrol or chlormadinone. The PRAC also starts the review on the risk of neurodevelopmental disorders with topiramate.
Subscribe to